Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Inflammatory Bowel Diseases

  Free Subscription


Articles published in J Clin Gastroenterol

Retrieve available abstracts of 40 articles:
HTML format



Single Articles


    November 2021
  1. BUFFONE E, Gupta S, Al Ibrahim B, Marshall JK, et al
    Week 2 Adalimumab Levels Predict Short-term Clinical Remission in Patients With Inflammatory Bowel Disease.
    J Clin Gastroenterol. 2021 Nov 10. pii: 00004836-900000000-97351.
    PubMed     Abstract available


  2. DAI C, Huang YH
    Biological Therapy in Chronic Antibiotic Refractory Pouchitis.
    J Clin Gastroenterol. 2021;55:911.
    PubMed    


    September 2021
  3. MARINELLI C, Zingone F, Lupo MG, Marin R, et al
    Serum Levels of PCSK9 Are Increased in Patients With Active Ulcerative Colitis Representing a Potential Biomarker of Disease Activity: A Cross-sectional Study.
    J Clin Gastroenterol. 2021 Sep 22. pii: 00004836-900000000-97369.
    PubMed     Abstract available


  4. JENA A, Dutta U, Shah J, Sharma V, et al
    Oral Fluconazole Therapy in Patients With Active Ulcerative Colitis Who Have Detectable Candida in the Stool: A Double-Blind Randomized Placebo-controlled Trial.
    J Clin Gastroenterol. 2021 Sep 9. pii: 00004836-900000000-97371.
    PubMed     Abstract available


  5. TANEJA V, El-Dallal M, Haq Z, Tripathi K, et al
    Effectiveness and Safety of Tofacitinib for Ulcerative Colitis: Systematic Review and Meta-analysis.
    J Clin Gastroenterol. 2021 Sep 9. pii: 00004836-900000000-97370.
    PubMed     Abstract available


  6. LIPCSEY M, Stein DJ, DeVore ZG, Feuerstein JD, et al
    Rising Rate of Obesity in Patients Admitted for Crohn's Disease Increases Costs But Not Mortality.
    J Clin Gastroenterol. 2021;55:716-720.
    PubMed     Abstract available


    July 2021
  7. AOUN R, Jabak S, Mourad FH, Francis FF, et al
    First or Second Biologic in Inflammatory Bowel Disease: Combination Therapy or Monotherapy?
    J Clin Gastroenterol. 2021 Jul 22. pii: 00004836-900000000-97390.
    PubMed     Abstract available


  8. HAIDER M, Lashner B
    Dual Targeted Therapy for the Management of Inflammatory Bowel Disease.
    J Clin Gastroenterol. 2021 Jul 8. pii: 00004836-900000000-97396.
    PubMed     Abstract available


  9. CHANDAN S, Mohan BP, Kumar A, Khan SR, et al
    Safety and Efficacy of Biological Therapy in Chronic Antibiotic Refractory Pouchitis: A Systematic Review With Meta-analysis.
    J Clin Gastroenterol. 2021;55:481-491.
    PubMed     Abstract available


    June 2021
  10. BARNES EL, Hanson JS, Regueiro MD, Saha S, et al
    Older Adult Patients Use More Aminosalicylate Monotherapy Compared With Younger Patients With Inflammatory Bowel Disease: TARGET-IBD.
    J Clin Gastroenterol. 2021 Jun 11. pii: 00004836-900000000-97401.
    PubMed     Abstract available


    May 2021
  11. ZAMSTEIN O, Glusman Bendersky A, Sheiner E, Landau D, et al
    Association Between Mode of Delivery of the Breech Fetus and Hospitalizations Due to Inflammatory Bowel Disease During Childhood.
    J Clin Gastroenterol. 2021 May 28. pii: 00004836-900000000-97416.
    PubMed     Abstract available


  12. DOLINGER MT, Choi JJ, Phan BL, Rosenberg HK, et al
    Use of Small Bowel Ultrasound to Predict Response to Infliximab Induction in Pediatric Crohn's Disease.
    J Clin Gastroenterol. 2021;55:429-432.
    PubMed     Abstract available


    April 2021
  13. KOCHAR B, Jiang Y, Long MD
    Patients With Inflammatory Bowel Diseases Are at Higher Risk for Meningitis.
    J Clin Gastroenterol. 2021;55:350-354.
    PubMed     Abstract available


    February 2021
  14. SCHLABITZ F, Teich N, Riesner-Wehner A, Bohm S, et al
    Inflammatory Bowel Disease and COVID-19: How Have Patients Coped So Far?
    J Clin Gastroenterol. 2021 Feb 3. pii: 00004836-900000000-97473.
    PubMed     Abstract available


  15. HASHASH JG, Beatty PL, Critelli K, Hartman DJ, et al
    Altered Expression of the Epithelial Mucin MUC1 Accompanies Endoscopic Recurrence of Postoperative Crohn's Disease.
    J Clin Gastroenterol. 2021;55:127-133.
    PubMed     Abstract available


    January 2021
  16. BANERJEE R, Pal P, Adigopula B, Reddy DN, et al
    Impact of Demographic, Clinical and Psychosocial Variables on Drug Adherence and Outcomes in Indian Patients With Inflammatory Bowel Disease: Cost is not the Only Factor!
    J Clin Gastroenterol. 2021;Publish Ahead of Print.
    PubMed     Abstract available


  17. MORTENSEN JH, van Haaften WT, Karsdal MA, Bay-Jensen AC, et al
    The Citrullinated and MMP-degraded Vimentin Biomarker (VICM) Predicts Early Response to Anti-TNFalpha Treatment in Crohn's Disease.
    J Clin Gastroenterol. 2021;55:59-66.
    PubMed     Abstract available


    November 2020
  18. SCHWARTZ J, Stein DJ, Lipcsey M, Li B, et al
    High Rates of Mortality in Geriatric Patients Admitted for Inflammatory Bowel Disease Management.
    J Clin Gastroenterol. 2020 Nov 23. doi: 10.1097/MCG.0000000000001458.
    PubMed     Abstract available


    October 2020
  19. KREDENTSER MS, Graff LA, Bernstein CN
    Psychological Comorbidity and Intervention in Inflammatory Bowel Disease.
    J Clin Gastroenterol. 2020 Oct 27. doi: 10.1097/MCG.0000000000001463.
    PubMed     Abstract available


  20. TUNIO NA, Mansoor E, Sheriff MZ, Cooper GS, et al
    Epidemiology of Autoimmune Hepatitis (AIH) in the United States Between 2014 and 2019: A Population-based National Study.
    J Clin Gastroenterol. 2020 Oct 16. doi: 10.1097/MCG.0000000000001449.
    PubMed     Abstract available


  21. EL AMROUSY D, El Ashry H, Hodeib H, Hassan S, et al
    Vitamin D in Children With Inflammatory Bowel Disease: A Randomized Controlled Clinical Trial.
    J Clin Gastroenterol. 2020 Oct 14. doi: 10.1097/MCG.0000000000001443.
    PubMed     Abstract available


  22. RITTER E, Hirsch A, Isakov NF, Ron Y, et al
    Higher Maintenance Adalimumab Trough Levels are Associated With Achievement of Advanced Remission Targets in Patients With Inflammatory Bowel Disease.
    J Clin Gastroenterol. 2020 Oct 14. doi: 10.1097/MCG.0000000000001435.
    PubMed     Abstract available


  23. CROOKS B, McLaughlin J, Limdi JK
    Disease-related Knowledge of People With Older-onset Inflammatory Bowel Disease.
    J Clin Gastroenterol. 2020 Oct 5. doi: 10.1097/MCG.0000000000001441.
    PubMed    


    September 2020
  24. BANERJEE R, Pal P, Penmetsa A, Kathi P, et al
    Novel Bioenhanced Curcumin With Mesalamine for Induction of Clinical and Endoscopic Remission in Mild-to-Moderate Ulcerative Colitis: A Randomized Double-Blind Placebo-controlled Pilot Study.
    J Clin Gastroenterol. 2020 Sep 4. doi: 10.1097/MCG.0000000000001416.
    PubMed     Abstract available


    August 2020
  25. SHIRZAD-ASKI H, Besharat S, Kienesberger S, Sohrabi A, et al
    Association Between Helicobacter pylori Colonization and Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    J Clin Gastroenterol. 2020 Aug 21. doi: 10.1097/MCG.0000000000001415.
    PubMed     Abstract available


  26. SHRESTHA MP, Taleban S
    Colectomy Rates Are Increasing Among Inpatients With Concomitant Ulcerative Colitis and Clostridioides difficile.
    J Clin Gastroenterol. 2020 Aug 14. doi: 10.1097/MCG.0000000000001412.
    PubMed     Abstract available


    July 2020
  27. MODESTO I
    Inhibitors of the Janus Kinases: A New Oral Treatment Option for Ulcerative Colitis.
    J Clin Gastroenterol. 2020 Jul 29. doi: 10.1097/MCG.0000000000001404.
    PubMed    


  28. LEE SD, Shivashankar R, Quirk D, Zhang H, et al
    Therapeutic Drug Monitoring for Current and Investigational Inflammatory Bowel Disease Treatments.
    J Clin Gastroenterol. 2020 Jul 29. doi: 10.1097/MCG.0000000000001396.
    PubMed     Abstract available


  29. ELIAS ED, Bernstein CN, Singh H, Oketola A, et al
    Dose Augmentation of Tumor Necrosis Factor Inhibitors is Frequently Performed in Persons With Inflammatory Bowel Disease in the Absence of Objective Evidence of Active Inflammation.
    J Clin Gastroenterol. 2020 Jul 17. doi: 10.1097/MCG.0000000000001391.
    PubMed     Abstract available


  30. FRESAN ORELLANA A, Parra Holguin NN, Yamamoto-Furusho JK
    Mental Health Factors Associated With Fatigue in Mexican Patients With Inflammatory Bowel Disease.
    J Clin Gastroenterol. 2020 Jul 14. doi: 10.1097/MCG.0000000000001397.
    PubMed     Abstract available


  31. DOEVE BH, van de Meeberg MM, van Schaik FDM, Fidder HH, et al
    A Systematic Review With Meta-Analysis of the Efficacy of Cannabis and Cannabinoids for Inflammatory Bowel Disease: What Can We Learn From Randomized and Nonrandomized Studies?
    J Clin Gastroenterol. 2020 Jul 14. doi: 10.1097/MCG.0000000000001393.
    PubMed     Abstract available


  32. FAN L, Wong M, Fan XS, Hong Y, et al
    Quantitative Analysis of Intramucosal Mast Cells in Irritable Bowel Syndrome: A Comparison With Inflammatory Bowel Disease in Remission.
    J Clin Gastroenterol. 2020 Jul 8. doi: 10.1097/MCG.0000000000001394.
    PubMed     Abstract available


    June 2020
  33. ALMON E, Shaaltiel Y, Sbeit W, Fich A, et al
    Novel Orally Administered Recombinant Anti-TNF Alpha Fusion Protein for the Treatment of Ulcerative Colitis: Results From a Phase 2a Clinical Trial.
    J Clin Gastroenterol. 2020 Jun 3. doi: 10.1097/MCG.0000000000001314.
    PubMed     Abstract available


    April 2020
  34. SCHOFFEL N, Bruggmann D, Klingelhofer D, Bendels MHK, et al
    Ulcerative Colitis: A Critical Approach to the Global Research Output Employing Density-equalizing Mapping and Scientometric Methods.
    J Clin Gastroenterol. 2020 Apr 21. doi: 10.1097/MCG.0000000000001351.
    PubMed     Abstract available


  35. CAMPBELL JP, Zierold C, Rode AM, Blocki FA, et al
    Clinical Performance of a Novel LIAISON Fecal Calprotectin Assay for Differentiation of Inflammatory Bowel Disease From Irritable Bowel Syndrome.
    J Clin Gastroenterol. 2020 Apr 21. doi: 10.1097/MCG.0000000000001359.
    PubMed     Abstract available


    January 2020
  36. HELWIG U, Kostev K, Schmidt C
    Comparative Analysis of 3-Year Persistence With Vedolizumab Compared With Antibodies Against Tumor Necrosis Factor-Alpha in Patients With Inflammatory Bowel Disease in Germany: Retrospective Analysis of a Large Prescription Database.
    J Clin Gastroenterol. 2020 Jan 31. doi: 10.1097/MCG.0000000000001323.
    PubMed     Abstract available


    November 2019
  37. DETREZ I, Thomas D, Van Steen K, Ballet V, et al
    Successful Infliximab Treatment is Associated With Reversal of Clotting Abnormalities in Inflammatory Bowel Disease Patients.
    J Clin Gastroenterol. 2019 Nov 26. doi: 10.1097/MCG.0000000000001290.
    PubMed     Abstract available


  38. KIM JY, Yoon H, Hwang JS, Yang SK, et al
    Comparison of Disease-related Knowledge of Patients With Inflammatory Bowel Disease Between the West and the East Using an Updated Questionnaire (IBD-KNOW).
    J Clin Gastroenterol. 2019 Nov 19. doi: 10.1097/MCG.0000000000001283.
    PubMed     Abstract available


    March 2019
  39. CAPURSO L
    Thirty Years of Lactobacillus rhamnosus GG: A Review.
    J Clin Gastroenterol. 2019;53 Suppl 1:S1-S41.
    PubMed     Abstract available


    January 2019
  40. HASHASH JG, Vachon A, Ramos Rivers C, Regueiro MD, et al
    Predictors of Suicidal Ideation Among IBD Outpatients.
    J Clin Gastroenterol. 2019;53:e41-e45.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: